INCY
INCY
NASDAQ · Biotechnology

Incyte Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$98.56
+0.79 (+0.81%)
As of May 9, 1:05 AM ET ·
Analyst Consensus
Hold
33
Analysts
Very High
Coverage
Buy 16 48%
Hold 16 48%
Sell 1 3%
Price Target
Analyst Price Target +109.8% upside
Low Target $125.25
Average Target $206.81
High Target $260.19
Current Price $98.56
Current
$98.56
Target
$206.81
$125.25 $206.81 avg $260.19
Scenario Analysis
Bear Case
$125.25
27.1%
Low target
Base Case
$206.81
+109.8%
Avg target
Bull Case
$260.19
+164.0%
High target
Risk/Reward
6.1x
Highly favorable
Price in Context
52-Week High
$112.29
-12.2% from high
52-Week Low
$57.77
+70.6% from low
50-Day SMA
$101.74
-3.1% vs SMA
200-Day SMA
$86.15
+14.4% vs SMA
RSI (14)
51.1
Neutral
Target vs 52W High
$206.81
+84.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%